KHINDIVI is the first and only FDA-approved hydrocortisone oral solution• Commercial launch expected the week of June 2nd• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocort ...

Profit before tax (PBT) stood at Rs 53.93 crore in Q4 FY25, down 41.94% year-on-year but up 31.89% quarter-on-quarter.